Published Erratum
doi: 10.1038/s41586-025-08827-0.
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Ignacio Melero
1
2
, Maria de Miguel Luken
3
, Guillermo de Velasco
4
, Elena Garralda
5
, Juan Martín-Liberal
6
, Markus Joerger
7
, Guzman Alonso
8
, Maria-Elisabeth Goebeler
9
, Martin Schuler
10
11
, David König
12
, Reinhard Dummer
13
, Maria Reig
14
15
, Maria-Esperanza Rodriguez Ruiz
16
, Emiliano Calvo
3
, Jorge Esteban-Villarrubia
4
, Arjun Oberoi
5
, Paula Sabat
6
, Juan José Soto-Castillo
6
, Kira-Lee Koster
7
, Omar Saavedra
8
, Cyrus Sayehli
9
, Tanja Gromke
10
11
, Heinz Läubli
12
, Egle Ramelyte
13
, Marta Fortuny
14
15
, Ana Landa-Magdalena
16
, Irene Moreno
3
, Javier Torres-Jiménez
4
, Alberto Hernando-Calvo
5
, Dagmar Hess
7
, Fabricio Racca
8
, Heike Richly
10
11
, Andreas M Schmitt
12
, Corinne Eggenschwiler
13
, Marco Sanduzzi-Zamparelli
14
15
, Anna Vilalta-Lacarra
16
, Jörg Trojan
17
, Christine Koch
17
, Peter R Galle
18
, Friedrich Foerster
18
, Zlatko Trajanoski
19
, Hubert Hackl
19
, Falk Gogolla
19
, Florestan J Koll
20
, Peter Wild
21
, Felix Kyoung Hwan Chun
20
, Henning Reis
21
, Peter Lloyd
22
, Matthias Machacek
23
, Thomas F Gajewski
24
, Wolf H Fridman
25
, Alexander M M Eggermont
26
27
, Ralf Bargou
28
, Sandra Schöniger
29
, Josef Rüschoff
29
, Anastasiia Tereshchenko
29
, Carina Zink
30
, Antonio da Silva
31
, Felix S Lichtenegger
32
, Julia Akdemir
32
, Manfred Rüdiger
32
, Phil L'Huillier
32
, Aradhana Dutta
32
, Markus Haake
32
, Alexandra Auckenthaler
32
, Ana Gjorgjioska
32
, Bernhard Rössler
32
, Frank Hermann
32
, Mara Liebig
32
, Daniela Reichhardt
32
, Christine Schuberth-Wagner
32
, Jörg Wischhusen
33
, Petra Fettes
32
, Marlene Auer
32
, Kathrin Klar
32
, Eugen Leo
34
Affiliations
Affiliations
- 1 Clínica Universidad de Navarra, CIMA, IDISNA and CIBERONC, Pamplona, Spain. imelero@unav.es.
- 2 Nuffield Department of Medicine, University of Oxford, Oxford, UK. imelero@unav.es.
- 3 START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
- 4 Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.
- 5 Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
- 6 Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.
- 7 Department of Medical Oncology & Hematology, Cantonal Hospital, St Gallen, Switzerland.
- 8 NEXT Oncology Phase I Unit/IOB - Hospital Quirónsalud Barcelona, Barcelona, Spain.
- 9 Medizinische Klinik 2, Early Clinical Trial Unit, University Hospital Würzburg, Würzburg, Germany.
- 10 West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.
- 11 National Center for Tumor Diseases (NCT) West, Essen, Germany.
- 12 Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
- 13 Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- 14 Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) & Liver Oncology Unit, Liver Unit, Hospital Clínic, Barcelona, Spain.
- 15 Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
- 16 Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
- 17 Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.
- 18 Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- 19 Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
- 20 Department of Urology, Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany.
- 21 Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany.
- 22 KinDyn Consulting, Warnham, UK.
- 23 LYO-X AG, Basel, Switzerland.
- 24 The University of Chicago Medical Center, Chicago, IL, USA.
- 25 Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université Paris Cité, Paris, France.
- 26 University Medical Center Utrecht and Princess Máxima Center, Utrecht, The Netherlands.
- 27 Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig-Maximilian University, Munich, Germany.
- 28 Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
- 29 Discovery Life Sciences Biomarker Services, Kassel, Germany.
- 30 Metronomia Clinical Research, Munich, Germany.
- 31 da Silva Consulting Services, Munich, Germany.
- 32 CatalYm, Munich, Germany.
- 33 Department of Gynecology, University Hospital Würzburg, Würzburg, Germany.
- 34 CatalYm, Munich, Germany. eugen.leo@catalym.com.
- PMID: 40000750
- PMCID: PMC11903306
- DOI: 10.1038/s41586-025-08827-0
Item in Clipboard
Published Erratum
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Ignacio Melero et al.
Nature.
2025 Mar.
Display options
Format
doi: 10.1038/s41586-025-08827-0.
Authors
Ignacio Melero
1
2
, Maria de Miguel Luken
3
, Guillermo de Velasco
4
, Elena Garralda
5
, Juan Martín-Liberal
6
, Markus Joerger
7
, Guzman Alonso
8
, Maria-Elisabeth Goebeler
9
, Martin Schuler
10
11
, David König
12
, Reinhard Dummer
13
, Maria Reig
14
15
, Maria-Esperanza Rodriguez Ruiz
16
, Emiliano Calvo
3
, Jorge Esteban-Villarrubia
4
, Arjun Oberoi
5
, Paula Sabat
6
, Juan José Soto-Castillo
6
, Kira-Lee Koster
7
, Omar Saavedra
8
, Cyrus Sayehli
9
, Tanja Gromke
10
11
, Heinz Läubli
12
, Egle Ramelyte
13
, Marta Fortuny
14
15
, Ana Landa-Magdalena
16
, Irene Moreno
3
, Javier Torres-Jiménez
4
, Alberto Hernando-Calvo
5
, Dagmar Hess
7
, Fabricio Racca
8
, Heike Richly
10
11
, Andreas M Schmitt
12
, Corinne Eggenschwiler
13
, Marco Sanduzzi-Zamparelli
14
15
, Anna Vilalta-Lacarra
16
, Jörg Trojan
17
, Christine Koch
17
, Peter R Galle
18
, Friedrich Foerster
18
, Zlatko Trajanoski
19
, Hubert Hackl
19
, Falk Gogolla
19
, Florestan J Koll
20
, Peter Wild
21
, Felix Kyoung Hwan Chun
20
, Henning Reis
21
, Peter Lloyd
22
, Matthias Machacek
23
, Thomas F Gajewski
24
, Wolf H Fridman
25
, Alexander M M Eggermont
26
27
, Ralf Bargou
28
, Sandra Schöniger
29
, Josef Rüschoff
29
, Anastasiia Tereshchenko
29
, Carina Zink
30
, Antonio da Silva
31
, Felix S Lichtenegger
32
, Julia Akdemir
32
, Manfred Rüdiger
32
, Phil L'Huillier
32
, Aradhana Dutta
32
, Markus Haake
32
, Alexandra Auckenthaler
32
, Ana Gjorgjioska
32
, Bernhard Rössler
32
, Frank Hermann
32
, Mara Liebig
32
, Daniela Reichhardt
32
, Christine Schuberth-Wagner
32
, Jörg Wischhusen
33
, Petra Fettes
32
, Marlene Auer
32
, Kathrin Klar
32
, Eugen Leo
34
Affiliations
- 1 Clínica Universidad de Navarra, CIMA, IDISNA and CIBERONC, Pamplona, Spain. imelero@unav.es.
- 2 Nuffield Department of Medicine, University of Oxford, Oxford, UK. imelero@unav.es.
- 3 START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
- 4 Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.
- 5 Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
- 6 Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.
- 7 Department of Medical Oncology & Hematology, Cantonal Hospital, St Gallen, Switzerland.
- 8 NEXT Oncology Phase I Unit/IOB - Hospital Quirónsalud Barcelona, Barcelona, Spain.
- 9 Medizinische Klinik 2, Early Clinical Trial Unit, University Hospital Würzburg, Würzburg, Germany.
- 10 West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.
- 11 National Center for Tumor Diseases (NCT) West, Essen, Germany.
- 12 Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
- 13 Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- 14 Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) & Liver Oncology Unit, Liver Unit, Hospital Clínic, Barcelona, Spain.
- 15 Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
- 16 Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
- 17 Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.
- 18 Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- 19 Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
- 20 Department of Urology, Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany.
- 21 Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany.
- 22 KinDyn Consulting, Warnham, UK.
- 23 LYO-X AG, Basel, Switzerland.
- 24 The University of Chicago Medical Center, Chicago, IL, USA.
- 25 Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université Paris Cité, Paris, France.
- 26 University Medical Center Utrecht and Princess Máxima Center, Utrecht, The Netherlands.
- 27 Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig-Maximilian University, Munich, Germany.
- 28 Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
- 29 Discovery Life Sciences Biomarker Services, Kassel, Germany.
- 30 Metronomia Clinical Research, Munich, Germany.
- 31 da Silva Consulting Services, Munich, Germany.
- 32 CatalYm, Munich, Germany.
- 33 Department of Gynecology, University Hospital Würzburg, Würzburg, Germany.
- 34 CatalYm, Munich, Germany. eugen.leo@catalym.com.
- PMID: 40000750
- PMCID: PMC11903306
- DOI: 10.1038/s41586-025-08827-0
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martín-Liberal J, Joerger M, Alonso G, Goebeler ME, Schuler M, König D, Dummer R, Reig M, Rodriguez Ruiz ME, Calvo E, Esteban-Villarrubia J, Oberoi A, Sabat P, Soto-Castillo JJ, Koster KL, Saavedra O, Sayehli C, Gromke T, Läubli H, Ramelyte E, Fortuny M, Landa-Magdalena A, Moreno I, Torres-Jiménez J, Hernando-Calvo A, Hess D, Racca F, Richly H, Schmitt AM, Eggenschwiler C, Sanduzzi-Zamparelli M, Vilalta-Lacarra A, Trojan J, Koch C, Galle PR, Foerster F, Trajanoski Z, Hackl H, Gogolla F, Koll FJ, Wild P, Chun FKH, Reis H, Lloyd P, Machacek M, Gajewski TF, Fridman WH, Eggermont AMM, Bargou R, Schöniger S, Rüschoff J, Tereshchenko A, Zink C, da Silva A, Lichtenegger FS, Akdemir J, Rüdiger M, L'Huillier P, Dutta A, Haake M, Auckenthaler A, Gjorgjioska A, Rössler B, Hermann F, Liebig M, Reichhardt D, Schuberth-Wagner C, Wischhusen J, Fettes P, Auer M, Klar K, Leo E. Melero I, et al. Nature. 2025 Jan;637(8048):1218-1227. doi: 10.1038/s41586-024-08305-z. Epub 2024 Dec 11. Nature. 2025. PMID: 39663448 Free PMC article. Clinical Trial.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
